Page last updated: 2024-09-04

moxifloxacin and Black Death

moxifloxacin has been researched along with Black Death in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anisimov, BI; Ryzhko, IV; Trishina, AV; Tsuraeva, RI	1
Brown, DL; Drusano, GL; Eichas, A; Fikes, S; Files, K; Heine, HS; Kinzig-Schippers, M; Liu, W; Louie, A; Sörgel, F; VanScoy, B	1

Other Studies

2 other study(ies) available for moxifloxacin and Black Death

Article	Year
[Efficacy of levofloxacin, lomefloxacin and moxifloxacin vs. other fluoroquinolones in experimental plague due to FI+ and FI- strains of Yersinia pestis in Albino mice]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2009, Volume: 54, Issue:5-6 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Levofloxacin; Mice; Moxifloxacin; Ofloxacin; Plague; Quinolines; Species Specificity; Time Factors; Yersinia pestis	2009
Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2 Topics: Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Moxifloxacin; Mutation; Plague; Quinolines; Treatment Outcome; Yersinia pestis	2011

Article

Year

[Efficacy of levofloxacin, lomefloxacin and moxifloxacin vs. other fluoroquinolones in experimental plague due to FI+ and FI- strains of Yersinia pestis in Albino mice].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2009, Volume: 54, Issue:5-6

Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Levofloxacin; Mice; Moxifloxacin; Ofloxacin; Plague; Quinolines; Species Specificity; Time Factors; Yersinia pestis

2009

Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.

Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2

Topics: Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Moxifloxacin; Mutation; Plague; Quinolines; Treatment Outcome; Yersinia pestis

2011